Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Near death experience, Respiratory arrest, Seasonal allergy
Clinical narrative: she had interstitial lung disease.; she was picked up at home in ambulance, was not breathing, was totally passed out.; she was picked up at home in ambulance, was not breathing, was totally passed out.; did not feel good; tired; big infection/she got infected; allergies related to pollen; This is a spontaneous report received from a Consumer or other non HCP, Program ID.  An 80-year-old female patient received BNT162b2 (BNT162B2), on 09Oct2021 as dose 3 (booster), single (Lot number: EL001SO) at the age of 78 years, in arm for covid-19 immunisation. The patient's relevant medical history included: "hysterectomy" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: BNT162b2 (DOSE 1, SINGLE. LOT: EL9264. Administered in arm.), administration date: 05Feb2021, when the patient was 77-year-old, for COVID-19 immunisation; BNT162b2 (DOSE 2, SINGLE. LOT: EL9266.), administration date: 26Feb2021, when the patient was 77-year-old, for COVID-19 immunisation. The following information was reported: NEAR DEATH EXPERIENCE (hospitalization, life threatening), RESPIRATORY ARREST (hospitalization, life threatening) all with onset 06Feb2024, outcome "unknown" and all described as "she was picked up at home in ambulance, was not breathing, was totally passed out."; SEASONAL ALLERGY (non-serious) with onset Feb2024, outcome "unknown", described as "allergies related to pollen"; INFECTION (non-serious) with onset Feb2024, outcome "unknown", described as "big infection/she got infected"; INTERSTITIAL LUNG DISEASE (hospitalization) with onset Feb2024, outcome "unknown", described as "she had interstitial lung disease."; MALAISE (non-serious), outcome "unknown", described as "did not feel good"; FATIGUE (non-serious), outcome "unknown", described as "tired". The patient was hospitalized for near death experience, respiratory arrest (start date: Feb2024, hospitalization duration: 8 day(s)); for interstitial lung disease (start date: Feb2024). The clinical course was reported as follows: Patient had never smoked in her life. Had never taken illegal drugs, any of that kind of stuff. Patient reported that she had shrunk 4, 8. Around 06Feb2024, patient was picked up at home in ambulance, was not breathing, was totally passed out. Woke up in hospital, had no way of knowing, did not remember a thing except, being picked up and carried in chair she was sitting in, going down the stairs. Remembered waking up in hospital. Patient was in hospital, in Intensive Care Unit (ICU), 8 days. They were running all kinds of tests, to figure out what was going on. That was how they determined that, she had interstitial lung disease and she received her pills to take, regimen of different kinds, along the way. She did pulmonary rehab for 24 times. Of course, they gave her 3 to 5 years. She did not feel good, it made her tired, it did not feel like doing anything. She was sitting down and would love to go lie down. It was the worst thing she could do. Patient got so out of breath. She tried to get on stationary bike each morning for 3 or 4 minutes, was doing 2 minutes. She could walk to end of yard, to street and back. Patient took vitamins, not every day but, said one a day. Patient had big infection from that Death on arrival (DOA) thing. She had allergies related to pollen. Everything started then, when she got infected. The patient underwent the following laboratory tests and procedures: Body height: (unspecified date) shrunk is 4, 8; tests: (Feb2024) interstitial lung disease. Therapeutic measures were taken as a result of interstitial lung disease.